Company: ANTX
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0000950170-25-052852
Chunk: 38

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 38
---
 plan. Effective January 1, 2024, we began making discretionary matching contributions to participants under our 401(k) plan. On an annual basis, we match 100% of eligible contributions up to the first 3% of eligible compensation, with the total matching contribution for any participant to not exceed $7,500. Match contributions vest immediately. Equity Compensation Plan Information The following table provides information as of December 31, 2024 with respect to shares of our common stock that may be issued under our existing equity compensation plans.

| Plan Category                                              
 Equity compensation plans approved by security holders     | ﻿ | Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights |           |     | ﻿ | Weighted Average Exercise Price of Outstanding Options, Warrants and Rights |      |     | ﻿ | Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in the First Column) |           |
|:-----------------------------------------------------------|:--|:--------------------------------------------------------------------------------------------|----------:|:----|:--|:----------------------------------------------------------------------------|-----:|:----|:--|:--------------------------------------------------------------------------------------------------------------------------------------------------|----------:|
| Equity Incentive Plans(1)                                  | ﻿ |                                                                                             | 5,548,786 |     |   | $                                                                           | 8.25 |     |   |                                                                                                                                                   |   718,409 |
| 2022 Employee Stock Purchase Plan(2)                       | ﻿ |                                                                                             |         — |     |   | N/A                                                                         |      |     |   |                                                                                                                                                   |   563,731 |
| Equity compensation plans not approved by security holders |   |                                                                                             |         — |     |   |                                                                             |    — |     |   |                                                                                                                                                   |         — |
| Total                                                      |   |                                                                                             | 5,548,786 |     |   | N/A                                                                         |      |     |   |                                                                                                                                                   | 1,282,140 |

<div align='center'>20</div>

Consists of 5,032,275 shares of common stock underlying stock options outstanding under the 2017 Plan and 2022 Plan and the related weighted average exercise price of such stock options, 516,511 RSUs outstanding under the 2017 Plan and 2022 Plan and the number of shares remaining available for future issuance under the 2022 Plan. The 2022 Plan provides that the number of shares available for issuance under the 2022 Plan will